Etiological Spectrum with Diagnosis and Prognosis of Central Diabe- tes Insipidus needs Long Term Followup: A Single Centre Experience

Article history Received: 26 October 2020 Accepted: 17 November 2020 Published Online: 30 December 2020 Introduction: Central Diabetes insipidus (CDI) is a rare disorder caused by vasopressin deficiency characterized by the excretion of copious volumes of unconcentrated urine. Objective: To assess the etiological, clinical, biochemical and radiological spectrum of Central DI in our institute and long term follow up of these cases. Material and Methods: 32 patients with Central DI admitted in Department of Endocrinology, Guwahati Medical College, Assam in the last 2.5 years were included. Detailed clinical assessment, biochemical evaluation and MRI (Magnetic Resonance imaging) brain were done in all the patients. Central DI without any identifiable cause was considered Idiopathic and those with structural lesion in hypothalamic pituitary region were considered organic. Result: Idiopathic CDI was present in 12(37.5%) patients and 20(62.5%) patients had organic CDI with acute onset of presentation. 12(60%) patients with organic CDI present with neurological symptoms but 8(40%) patients had no neurological symptoms even with organic cause. Pituitary dysfunction was common in organic CDI as compared to idiopathic CDI. Paediatric patients commonly present with organic cause for CDI with low cortisol most common hormonal deficit. One patient of idiopathic CDI with normal stalk thickness at baseline presented with clinical and radiological features of LCH(Langerhans cell histiocytosis) on follow up. Conclusion: Organic CDI more likely to have acute onset of presentation than idiopathic CDI and even in absence of neurological features. Paediatric patients commonly have organic cause for CDI. We propose the paramount importance of long-term clinical follow-up and reassessment of endocrine function in patients with CDI for definitive diagnosis of autoimmune and inflammatory causes of idiopathic CDI and timely treatment of pituitary hypofunction.